SEARCH

SEARCH BY CITATION

References

  • 1
    Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 148190.
  • 2
    Furlan A, Irwin E, Bombardier C. Limited search strategies were effective in finding relevant nonrandomized studies. J Clin Epidemiol 2006; 59: 130311.
  • 3
    Gelman A, Carlin J, Stern H, Rubin H. Bayesian data analysis. New York: Chapman and Hall, 1995.
  • 4
    Abu-shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum 1996; 39: 10504.
  • 5
    Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001; 10: 394400.
  • 6
    Nived O, Bengsston A, Jonsen A, Sturfelt G, Olson H. Malignancies during follow-up in an epidemiologically defined SLE inception cohort in southern Sweden. Lupus 2001; 10: 5004.
  • 7
    Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL. Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med 1998; 46: 21722.
  • 8
    Sultan SM, Ioannou Y, Isenberg DA. Is there an association of malignancy with systemic lupus erythematosus? Rheumatology 2000; 39: 114752.
  • 9
    Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA Jr, Ramsey-Goldman R. Risk of malignancy in women with SLE. J Rheumatol 1995; 22: 147882.
  • 10
    Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, Ju JH, Cho CS, Kim HY, Park SH. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol 2010; 29: 3818.
  • 11
    Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 6671.
  • 12
    Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 7618.
  • 13
    Parikh-Patel A, White RH, Allen M, Cress R. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control 2008; 19: 88794.
  • 14
    Carroll PR, Carducci MA, Zietman AL, Rothaermel JM. Report to the nation on prostate cancer. A guide to men and their families. Santa Monica, CA: Prostate Cancer Foundation, 2005.
  • 15
    Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000; 9: 2527.
  • 16
    Mononen N, Schleutker J. Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer. J Urol 2009; 181: 15419.
  • 17
    Varghese JS, Easton DF. Genome-wide association studies in common cancers—what have we learnt? Curr Opin Genet Dev 2010; 20: 2019.
  • 18
    Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin P, Gordon C, Barr S, Edworthy S, Bae SC, et al. Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum 2005; 53: 7814.
  • 19
    Bernatsky S, Clarke AE, Petri M, Urowitz M, Fortin PR, Gladman DD, Jacobsen S, Manzi S, Alarcon GS, Ginzler E, Peschken C, Dooley MA, Hanly JG, Nived O, Sturfelt GK, Senecal J-L, Labrecque J, Turnbull E, Lee JFL, Isenberg D, Rahman A, Ramsey-Goldman R. Further defining cancer risk in systemic lupus: updated results in an expanded international multi-centre cohort[Abstract] Arthr Rheum 2010: 62(Suppl); S731.
  • 20
    Bernatsky SR, Cooper GS, Mill C, Ramsey-Goldman R, Clarke AE, Pineau CA. Cancer screening in patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 459.
  • 21
    Health in the European Union. European Commission Report. Belgium; September 2007. Available at http://ec.europa.eu/health/ph_publication/eb_health_en.pdf accessed on Feb. 21, 2011.
  • 22
    Brasky TM, Velicer CM, Kristal AR, Peters U, Potter JD, White E. Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Epidemiol Biomarkers Prev 2010; 19: 31858.
  • 23
    Bernatsky S, Boivin JF, Joseph L, Gordon C, Urowitz M, Gladman D, Ginzler E, Fortin P, Bae SC, Barr S, Isenberg D, Rahman A, et al. The relationship between cancer and medication exposures in systemic lupus erythematosus: a case-cohort study. Ann Rheum Dis 2008; 67: 749.